Altimmune
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $26 | $5 | $5 | $5 |
Gross Profit | 26 | -14,955 | 5 | 5 |
EBITDA | -28,893 | -18,492 | -21,852 | -20,226 |
EBIT | -28,919 | -18,519 | -21,882 | -20,255 |
Net Income | -27,358 | -19,014 | -22,146 | -19,575 |
Net Change In Cash | 26 | 5 | 5 | 5 |
Free Cash Flow | -19,449 | -11,897 | -19,658 | -16,840 |
Cash | 43,760 | 61,236 | 183,105 | 49,104 |
Basic Shares | 100,613 | 89,418 | 81,477 | 75,547 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $41 | $20 | $426 | $-68 |
Gross Profit | -71 | 20 | 426 | -68 |
EBITDA | -94,489 | -94,812 | -87,935 | -84,409 |
EBIT | -94,601 | -95,050 | -88,412 | -84,902 |
Net Income | -88,093 | -95,059 | -88,447 | -84,713 |
Net Change In Cash | 41 | 20 | 426 | -68 |
Free Cash Flow | -67,546 | -79,848 | -75,857 | -62,712 |
Cash | 43,760 | 36,926 | 135,117 | 111,097 |
Basic Shares | 88,104 | 71,003 | 53,246 | 46,926 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.27 |
2025-09-30 | -$0.21 |
2025-06-30 | -$0.27 |
